Follow
Michael Jordan
Michael Jordan
Assistant Professor of Medicine, Tufts University
Verified email at tuftsmedicalcenter.org - Homepage
Title
Cited by
Cited by
Year
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update
DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ...
PloS one 4 (3), e4724, 2009
11162009
Highly parallel direct RNA sequencing on an array of nanopores
DR Garalde, EA Snell, D Jachimowicz, B Sipos, JH Lloyd, M Bruce, ...
Nature methods 15 (3), 201-206, 2018
10032018
Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global …
RK Gupta, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson, ...
The Lancet 380 (9849), 1250-1258, 2012
4652012
HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression …
RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ...
The Lancet infectious diseases 18 (3), 346-355, 2018
4192018
HIV-1 drug resistance and resistance testing
DS Clutter, MR Jordan, S Bertagnolio, RW Shafer
Infection, Genetics and Evolution 46, 292-307, 2016
3412016
Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and sequence-level meta-analysis
SY Rhee, JL Blanco, MR Jordan, J Taylor, P Lemey, V Varghese, ...
PLoS medicine 12 (4), e1001810, 2015
2822015
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...
Jama 329 (22), 1934-1946, 2023
2712023
Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring
JH McMahon, MR Jordan, K Kelley, S Bertagnolio, SY Hong, CA Wanke, ...
Clinical Infectious Diseases 52 (4), 493-506, 2011
1942011
Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis
TS Boender, KCE Sigaloff, JH McMahon, S Kiertiburanakul, MR Jordan, ...
Clinical Infectious Diseases 61 (9), 1453-1461, 2015
1772015
Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review
JH McMahon, JH Elliott, S Bertagnolio, R Kubiak, MR Jordan
Bulletin of the World Health Organization 91, 377-385, 2013
1652013
World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites
MR Jordan, DE Bennett, S Bertagnolio, CF Gilks, D Sutherland
Antiviral therapy 13 (2_suppl), 15-23, 2008
1622008
Impact of HIV drug resistance on HIV/AIDS-associated mortality, new infections, and antiretroviral therapy program costs in sub–Saharan Africa
AN Phillips, J Stover, V Cambiano, F Nakagawa, MR Jordan, D Pillay, ...
The Journal of infectious diseases 215 (9), 1362-1365, 2017
1302017
Dried blood spots for HIV-1 drug resistance and viral load testing: A review of current knowledge and WHO efforts for global HIV drug resistance surveillance.
S Bertagnolio, NT Parkin, M Jordan, J Brooks, JG García-Lerma
AIDS reviews 12 (4), 195-208, 2010
1202010
HIV-1 drug resistance mutations: potential applications for point-of-care genotypic resistance testing
SY Rhee, MR Jordan, E Raizes, A Chua, N Parkin, R Kantor, GU Van Zyl, ...
PloS one 10 (12), e0145772, 2015
1022015
A dual-constriction biological nanopore resolves homonucleotide sequences with high fidelity
SE Van der Verren, N Van Gerven, W Jonckheere, R Hambley, P Singh, ...
Nature biotechnology 38 (12), 1415-1420, 2020
952020
Transmission of drug resistant HIV and its potential impact on mortality and treatment outcomes in resource-limited settings
V Cambiano, S Bertagnolio, MR Jordan, JD Lundgren, A Phillips
The Journal of infectious diseases 207 (suppl_2), S57-S62, 2013
932013
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
AN Phillips, V Cambiano, F Nakagawa, P Revill, MR Jordan, TB Hallett, ...
The lancet HIV 5 (3), e146-e154, 2018
792018
HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 …
DE Bennett, MR Jordan, S Bertagnolio, SY Hong, G Ravasi, JH McMahon, ...
Clinical infectious diseases 54 (suppl_4), S280-S289, 2012
772012
Comparison of standard PCR/cloning to single genome sequencing for analysis of HIV-1 populations
MR Jordan, M Kearney, S Palmer, W Shao, F Maldarelli, EP Coakley, ...
Journal of virological methods 168 (1-2), 114-120, 2010
762010
Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004–2011
MR Jordan, DE Bennett, MA Wainberg, D Havlir, S Hammer, C Yang, ...
Clinical infectious diseases 54 (suppl_4), S245-S249, 2012
752012
The system can't perform the operation now. Try again later.
Articles 1–20